Fig. 2From: The impact of specific pulmonary arterial hypertension therapy on cardiac fluorodeoxyglucose distribution in PET/MRI hybrid imaging–follow-up studyCardiac 18-fluorodeoxyglucose uptake in pulmonary hypertension patient before A initiation of specific therapy and after B 24 months of treatmentBack to article page